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NMDA receptor subunit composition varies through-
out the brain, providing molecular diversity in NMDA
receptor function. The NR2 subunits (NR2A–D) in
large part dictate the distinct functional properties
of NMDA receptors and differentially regulate recep-
tor trafficking. Although the NR2C subunit is highly
enriched in cerebellar granule cells and plays a unique
role in cerebellar function, little is known about NR2C-
specific regulation of NMDA receptors. Here, we
demonstrate that PKB/Akt directly phosphorylates
NR2C on serine 1096 (S1096). In addition, we identify
14-3-33 as an NR2C interactor, whose binding is
dependent on S1096 phosphorylation. Both growth
factor stimulation and NMDA receptor activity lead
to a robust increase in both phosphorylation of
NR2C on S1096 and surface expression of cerebellar
NMDA receptors. Finally, we find that NR2C expres-
sion, unlike NR2A and NR2B, supports neuronal
survival. Thus, our data provide a direct mechanistic
link between growth factor stimulation and regulation
of cerebellar NMDA receptors.
INTRODUCTION
NMDA receptors are widely distributed in the CNS where they
regulate neuronal development and synaptic plasticity. NMDA
receptors are tetramers composed of homologous subunits
(NR1, NR2A–D, NR3A–B), but their precise subunit composition
varies at excitatory synapses throughout the brain and during
development (Cull-Candy and Leszkiewicz, 2004). Functional
NMDA receptors require both NR1 and NR2 subunits; however,
unlike NR1, there are multiple NR2 subunits, each with unique
spatiotemporal expression patterns, ensuring molecular diver-
sity in endogenous NMDA receptors. The NR2 subunit composi-
tion determines the functional properties of NMDA receptors
as well as the coupling of NMDA receptors to distinct intra-
cellular signaling pathways. Furthermore, at a given synapse,
the subunit composition of NMDA receptors can change in
response to experience and synaptic activity (Bellone and Nicoll,
2007). Ultimately, this precise regulation of NMDA receptorexpression at excitatory synapses regulates synaptic function
and plasticity of AMPA receptors.
The trafficking of NMDA receptors is tightly regulated. There is
evidence that NMDA receptor trafficking is governed by a variety
of mechanisms that regulate distinct intracellular trafficking path-
ways including ER-retention/egress, exocytosis, lateral diffusion
in the plasma membrane, and endocytosis followed by either
degradation or recycling (Groc and Choquet, 2006; Lau and Zu-
kin, 2007). The precise molecular mechanisms regulating NMDA
receptor trafficking depend on motifs located within the intracel-
lular C-termini of receptor subunits, often within the NR2 subunits
(Lau and Zukin, 2007; Wenthold et al., 2003). Protein phosphory-
lation is also an important mechanism regulating NMDA receptor
trafficking, as well as channel function. NMDA receptors are
directly phosphorylated by a variety of protein kinases, and the
substrate specificity is often subunit specific (Chen and Roche,
2007).
In cerebellar granule cells, the subunit composition of NMDA
receptors changes dramatically during development (Akazawa
et al., 1994; Monyer et al., 1994). NR2B is expressed early but
almost disappears by postnatal day 21 (Akazawa et al., 1994). In
contrast, NR2A and NR2C are not expressed early in development
but replace NR2B in mature neurons. In contrast to NR2A and
NR2B,which are highly expressed inmany regions of the forebrain,
NR2C is specifically enriched in cerebellar granule cells, suggest-
ing a unique role for this subunit in the regulation of cerebellar
neurons. NR2C-containing NMDA receptors have distinct charac-
teristics includingareducedsensitivity tomagnesiumandasmaller
conductance compared to NR2A- or NR2B-containing NMDA
receptors (Cull-Candy and Leszkiewicz, 2004). In addition, mice
expressing NR2C and NR2A with deleted C-terminal domains
have impaired cerebellar synaptic plasticity (Rossi et al., 2002),
and mice lacking NR2C display impaired motor coordination
(Sprengel et al., 1998), demonstrating a critical role for NR2C in
cerebellar function. However, there has been little characterization
of NR2C-specific regulation of glutamate receptor trafficking.
Cerebellar granule cells require growth factor signaling to
survive during development (Contestabile, 2002). Insulin-like
growth factor-1 (IGF-1), in particular, is essential to inhibit
apoptosis (Blair et al., 1999; Dudek et al., 1997). IGF-1 upregulates
PI3K and stimulates protein kinase B (PKB)/Akt, which phosphor-
ylates many cellular substrates (Brazil et al., 2004; Datta et al.,
1999). Although the IGF-1 signal transduction pathway has been
implicated in both NMDA receptor regulation and synaptic plas-
ticity (Peineau et al., 2007; Sanchez-Perez et al., 2006; SuttonNeuron 62, 471–478, May 28, 2009 ª2009 Elsevier Inc. 471
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phorylating any subtype of glutamate receptor. In the current
study, we now show that PKB phosphorylates NR2C on S1096,
thus regulating NMDA receptor trafficking by promoting the asso-
ciation of 14-3-33 with NR1/NR2C heteromeric receptors. Growth
factor stimulation or receptor activity trigger PKB-dependent traf-
ficking of cerebellar NMDA receptors to the cell surface. Further-
more, NR2C expression, unlike NR2A or NR2B, protects cere-
bellar granule cells in an NMDA toxicity assay. Thus, our
findings provide a novel link between growth factor stimulation,
NMDA receptor phosphorylation and trafficking, and neuronal
survival.
RESULTS
To identify NR2C interacting proteins, we screened a rat brain
yeast two-hybrid library with the NR2C C terminus (aa 1076–aa
1250; Figure 1A), and isolated 14-3-33 (see Figure S1 available
online). The mammalian 14-3-3 proteins consist of seven highly
homologous members that interact with a variety of proteins,
regulating signal transduction and protein trafficking. The 14-3-
3 family of proteins were originally isolated as abundant proteins
in the brain and are highly conserved in a broad range of eukary-
otic organisms.
To characterize the specificity of the NR2C-14-3-33 interac-
tion, we evaluated the binding of 14-3-33 to the C terminus of
NR2A, NR2B, or NR2C using yeast two-hybrid direct interaction
assays. By evaluating growth on histidine-deficient plates (His)
as an assay for protein-protein interactions, we observed no
specific binding when the C terminus of NR2A or NR2B was
coexpressed with 14-3-33 (Figure S1). In contrast, NR2C inter-
acted strongly with 14-3-33, demonstrating that the interaction
between 14-3-33 and NMDA receptors is specific for the NR2C
subunit.
Upon sequence examination, we found two regions (1093-R-H-
A-S-L-P-1098 and 1141-R-L-P-S-Y-P-1146) within the NR2C C
terminus that are similar to previously identified 14-3-3 binding
motifs, R-S-X-SP-X-P and R-X-X-X-SP-X-P (X can be any amino
acid and SP indicates a phosphorylated serine; Yaffe et al.,
1997). To determine whether these two regions of NR2C are
required for 14-3-33 binding, we tested the interaction of 14-3-33
with NR2C containing a mutation in the critical serine residue
within each putative binding site, S1096A (Figure 1A) or S1144A.
The NR2C S1096A mutation disrupted the 14-3-33 binding,
whereas NR2C S1144A mutant had no effect (Figure 1B), indi-
cating that S1096 is part of the 14-3-33 binding motif on NR2C.
We also examined 14-3-33binding to NR2C using a coimmuno-
precipitation assay in HEK293 cells expressing FLAG-NR2C or
FLAG-NR2C S1096A and Myc-14-3-33. Surprisingly, Myc-14-3-
33 was not coimmunoprecipitated efficiently with NR2C
(Figure 1C). Because NR2 subunits are ER-retained in the
absence of NR1, we reasoned that perhaps the correct assembly
of NR2C with NR1 is required for the 14-3-3 interactions. Indeed,
there is evidence that 14-3-3 family members preferentially bind
to assembled proteins in the ER-Golgi intermediate compartment
thus facilitating export of properly assembled multimers from the
ER (O’Kelly et al., 2002; Yuan et al., 2003). Consistent with this
hypothesis, we observed robust binding of 14-3-3 to NR2C only
upon co-transfection with NR1. Furthermore, the NR2C S1096A
mutation disrupted the NR2C-14-3-33 interaction (Figure 1C).
These results not only provided evidence that the R-H-A-S-L-P
(S1096) motif of NR2C is responsible for 14-3-3 binding but also
show that 14-3-33 specifically binds NR1/NR2C heteromers.
To investigate the interaction between NR2C and 14-3-33 in
neurons, 14-3-33 was immunoprecipitated from cerebellum
homogenate and immunoblotted with an NR2C antibody, which
also cross-reacted with NR2A and NR2B. Consistent with the
results from yeast two-hybrid interaction assay, we found that
NR2C, but not NR2A and NR2B, coimmunoprecipitated with
14-3-33 (Figure 1D), demonstrating that NR2C is a specific
binding partner for 14-3-33 in vivo.
A
B
C D
- -
- -
- -
I I I I I I
I I I I I I
- -
- -
-
-
- -
-
- -
Figure 1. NR2C Specifically Interacts with 14-3-33, and Binding Is
Regulated by S1096
(A) Schematic diagram of NR2C including an alignment of NR2A (amino acids
1281–1300), NR2B (amino acids 1293–1312), and NR2C (amino acids 1086–
1105). NR2C S1096 is indicated with an arrowhead, and NR2A S1291 and
NR2B S1303 are indicated with asterisks. The shaded area indicates aa
1076 to aa 1250 of NR2C, which was used as bait in the yeast two-hybrid
screen.
(B) Yeast were cotransformed with LexA-NR2C WT, LexA-NR2C S1096A, or
LexA-NR2C S1144A and either Gal4 vector or Gal4-14-3-33, and growth
was evaluated on appropriate yeast selection medium. Results shown are
10-fold serial dilutions of yeast cells.
(C) HEK293 cells were transiently transfected with FLAG-NR2C or FLAG-
NR2C S1096A and Myc-14-3-33 with or without NR1-1a. Receptors were
immunoprecipitated from cell lysates with anti-FLAG antibodies or IgG anti-
bodies as a negative control. Immunoprecipitates were resolved by SDS-
PAGE and immunoblotted with anti-Myc antibodies. Input = 2% of total lysate.
(D) Adult rat cerebella were solubilized, and 14-3-33 was immunoprecipitated
from lysates with anti-14-3-33 antibodies or IgG antibodies as a control. Immu-
noprecipitates were resolved by SDS-PAGE and immunoblotted with anti-
NR2C antibodies. Input = 5% of total lysate.472 Neuron 62, 471–478, May 28, 2009 ª2009 Elsevier Inc.
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phorylation, and many sites have been identified on the C-termini
of NR2 subunits (Chen and Roche, 2007). Because 14-3-3
proteins typically bind to phosphorylated serine residues (Yaffe
et al., 1997) and S1096 on NR2C is required for 14-3-3 binding,
we investigated whether S1096 on NR2C is phosphorylated.
Interestingly, sequence examination revealed a prototypical
PKB consensus motif surrounding S1096 in the NR2C intracel-
lular C terminus, which coincides with the 14-3-3 binding motif
(Figure 1A). Although the serine is conserved in other NR2
subunits, the entire PKB recognition motif is not (Figure 1A). We
performed in vitro phosphorylation assays using GST fusion
proteins (GST, GST-NR2C wild-type (WT) or GST-NR2C S1096A)
incubated with recombinant PKB. The equal loading of GST-
NR2C fusion proteins was confirmed by Coomassie blue staining
(data not shown). GST-NR2C WT and GST-NR2C S1244A were
efficiently phosphorylated by PKB in vitro (Figure S2A), but
reduced phosphorylation was observed for GST-NR2C S1096A
(Figure S2A), demonstrating the direct phosphorylation of S1096
by PKB in vitro. The residual phosphorylation of GST-NR2C
S1096A indicates that there is a second site on NR2C that PKB
phosphorylates in vitro, although less efficiently than S1096.
We next raised a phosphorylation state-specific polyclonal
antibody recognizing phosphorylated S1096 that specifically
detected PKB phosphorylated GST-NR2C fusion protein
(Figure S2B). In contrast, the antibody did not recognize GST-
NR2C S1096A even when the fusion protein was incubated
with PKB (Figure S2B), demonstrating the direct phosphorylation
of S1096 by PKB in vitro and confirming the specificity of the
antibody for NR2C phosphorylated on S1096.
To test if NR2C S1096 is phosphorylated upon PKB activation
in situ, we coexpressed NR2C with a constitutively active form of
PKB (caPKB; Cong et al., 1997) in HEK293 cells. Coexpression
of NR2C with either caPKB or a dominant-negative form of
PKB (dnPKB) in HEK293 cells did not affect NR2C expression
(Figure 2A). The phosphorylation of S1096 increased dramati-
cally upon cotransfection with caPKB, but no increase was
observed for NR2C S1096A or for NR2C WT or NR2C S1096A
coexpressed with dnPKB (Figure 2A). Similar results were
obtained when NR1 was co-transfected with NR2C and caPKB
or dnPKB (Figure S3A).
Various growth factors stimulate the phosphoinositide
3-kinase (PI3K) signal transduction cascade, which results in
the activation of PKB (Datta et al., 1999). Because HEK293 cells
are insulin sensitive, we investigated whether IGF-1 treatment,
which activates PKB via PI3K, would stimulate NR2C phosphor-
ylation on S1096. We observed a marked increase in NR2C
S1096 phosphorylation in response to PKB activation that was
blocked by incubation with the PI3K inhibitor wortmannin to
prevent activation of the PI3K-PKB pathway (Figure 2B). Taken
together, these results demonstrate that IGF-1, through the
activation of PI3K/PKB pathway, is able to induce NR2C S1096
phosphorylation. Similar results were obtained when NR2C was
co-transfected with NR1 (Figure S3B).
To evaluate the phosphorylation of endogenous NR2C,
we analyzed NR2C isolated from mouse cerebellum slices (pre-
pared from P12 animals). Immunoblots probed with the NR2C
S1096 phosphorylation state-specific antibody revealed thatendogenous NR2C was phosphorylated on S1096 (Figure 2C).
Furthermore, treatment of the membrane with lambda-phospha-
tase prior to immunoblotting eliminated the NR2C band recog-
nized with the S1096 phosphorylation state-specific antibody
(Figure 2C), confirming that the immunoreactivity was specific
for phosphorylated NR2C. NR2C is expressed at a very low
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Figure 2. NR2C Is Phosphorylated on S1096 by PKB, and Phosphor-
ylation Is Regulated by IGF-I and NMDA Receptor Activity
(A) HEK293 cells were cotransfected with NR2C WT or NR2C S1096A and
vector, caPKB or dnPKB, and immunoblots of cell lysate were probed with
either the NR2C antibody or NR2C S1096 phosphorylation state-specific anti-
body.
(B) HEK293 cells expressing NR2C were treated for 10 min ± wortmannin, and
the cells were stimulated for 10 min ± IGF-I in the continued presence or
absence of wortmannin. The immunoblots of cell lysate were probed with
either the NR2C antibody or NR2C S1096 phosphorylation-state specific anti-
body.
(A and B) The data were quantified by measuring phosphorylated NR2C/NR2C
band intensity ratios using ImageJ software and normalizing to either NR2C
with caPKB (A) or NR2C with IGF-I (B). Data represent means ± SEM (n = 3).
(C) Cerebellum and hippocampus from a P12 mouse were solubilized, and
NR2C was immunoprecipitated from lysates, resolved by SDS-PAGE
and immunoblotted with antibodies as indicated. Recognition of phosphory-
lated NR2C was prevented following l phosphatase treatment of immuno-
blots.
(D–F) Cultured cerebellar granule cells were treated ± IGF-I (50 ng/ml), NMDA
(50 mM), or APV (50 mM) for various times as indicated. NR2C was immunopre-
cipitated from lysates, resolved by SDS-PAGE, and immunoblotted with either
the NR2C antibody or the NR2C S1096 phosphorylation state-specific anti-
body. The data were quantified by measuring phosphorylated NR2C/input
NR2C band intensity ratios using ImageJ software and normalizing to
untreated NR2C WT control cultures. Data represent means ± SEM (n = 3;
*p < 0.05).Neuron 62, 471–478, May 28, 2009 ª2009 Elsevier Inc. 473
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Figure 3. PKB Phosphorylation of NR2C on S1096 Increases NMDA Receptor Surface Expression
(A) HEK293 cells were cotransfected with NR1-1a-IRES-DsRed, FLAG-NR2C-IRES-EGFP and vector, caPKB, or dnPKB. Cells were collected and analyzed
by FACS analysis (see Experimental Procedures). Bar plot showing the normalized ratio of NR2C, EGFP and DsRed expressed cells versus EGFP and DsRed
expressed cells. Data represent means ± SEM (n = 3; *p < 0.05).
(B) HEK293 cells expressing NR1-1a and NR2C WT or NR2C S1096A were incubated ± IGF-I for 20 min before biotinylating surface proteins. Total lysates were
compared to surface pools of proteins by immunoblotting with the NR2C antibody. The data were quantified by measuring surface NR2C/input NR2C band inten-
sity ratios using ImageJ software and normalizing to untreated NR2C WT control cultures. Data represent means ± SEM (n = 3; *p < 0.05).
(C and D) Cultured cerebellar granule cells were treated ±IGF-I (50 ng/ml) (C) or NMDA (50 mM) (D) before biotinylating surface proteins. Total lysates were
compared with surface pools of proteins by immunoblotting with the NR2C antibody. Data was quantified using ImageJ software. Data represent means ±
SEM (n = 3; *p < 0.05).level in hippocampus compared to cerebellum, accordingly in
hippocampus we observed only a low level of NR2C expression
(Figure 2C).
To investigate if S1096 phosphorylation on endogenous
NR2C is dynamically regulated in neurons, we treated cultured
cerebellar granule cells (12 days in vitro) with IGF-1 for various
periods of time to stimulate PKB activity. Immunoblot analysis
with the NR2C S1096 phosphorylation state-specific antibody
revealed that NR2C S1096 is phosphorylated even in the absence
of IGF-1, indicating that there is a modest basal level of phosphor-
ylation in cerebellar granule cells. However, IGF-1 treatment
resulted in a dramatic increase in phosphorylation of NR2C
S1096 (Figure 2D), showing that endogenous NR2C S1096 is
regulated by PKB in vivo. NMDA receptor activation has been
shown to stimulate PKB activity (Lafon-Cazal et al., 2002);
therefore, we examined if agonist exposure regulates phosphory-
lation of NR2C S1096 and found that brief NMDA treatment tran-
siently increased phosphorylation of NR2C S1096 (Figure 2E).
In contrast, application of the NMDA receptor antagonist
APV decreased NR2C S1096 phosphorylation over the same
time course (Figure 2F), revealing a tonic stimulation of NR2C
S1096 phosphorylation by endogenous glutamate. These results
demonstrate that both IGF-1 and NMDA receptor activity regulate
phosphorylation of NR2C on S1096 in cerebellar granule cells.
Phosphorylation of ionotropic glutamate receptors is an impor-
tant mechanism modulating receptor trafficking (Lee, 2006). We
therefore examined if PKB phosphorylation of NR2C affects
surface expression of NR2C-containing NMDA receptors using
fluorescence activated cell sorting (FACS) analysis. A bicistronic
expression construct containing the coding sequence of FLAG-
tagged NR2C and EGFP was used to monitor NR2C-transfected
cells (GFP-positive cells), and a second bicistronic expression474 Neuron 62, 471–478, May 28, 2009 ª2009 Elsevier Inc.construct containing the coding sequence of NR1-1a and DsRed
was used to monitor NR1-1a-transfected cells (DsRed-positive
cells). Surface expression of FLAG-NR2C in live HEK293 cells
expressing both GFP and DsRed was measured. We found that
caPKB dramatically increased wild-type NR2C surface expres-
sion, whereas expression of caPKB resulted in only a modest
increase in the surface expression of NR2C S1096A (Figure 3A),
demonstrating that S1096 primarily mediates the PKB-dependent
increase in NMDA receptor surface expression.
We also measured the effects of PKB on surface expression
of NR2C/NR1 heteromers in HEK293 cells using a cell surface
biotinylation assay. We found that IGF-1 treatment robustly
increased surface expression of NR2C WT with only a modest
effect on NR2C S1096A (Figure 3B). a-Tubulin, an intracellular
protein, was used as a negative control for surface biotinylation.
To determine whether surface expression of endogenous
NR2C is regulated by PKB phosphorylation in neurons, we
treated cultured cerebellar granule cells with IGF-1 and per-
formed a cell surface biotinylation assay. IGF-1 treatment
dramatically increased surface expression of NR2C in cerebellar
granule cells (Figure 3C), and the increase was blocked by pre-
incubation with the PI3K inhibitor wortmannin or LY294002 prior
to IGF-1 treatment (Figures S4A and S4C). We also treated
cultured cerebellar granule cells with NMDA and evaluated
receptor surface expression using the cell surface biotinylation
assay. Interestingly, NMDA treatment also dramatically upregu-
lated surface expression of endogenous NR2C (Figure 3D),
which can be blocked by preincubation with wortmannin or
LY294002 (Figures S4B and S4C). Taken together, these data
demonstrate that PKB phosphorylation of NR2C S1096 driven
by IGF-1 signaling or NMDA receptor activation facilitates
NR2C trafficking to the plasma membrane.
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NR2C is required for receptor trafficking in neurons, but these
experiments did not specifically address the role of 14-3-33 in
regulating surface expression of NR2C. To determine whether
14-3-33 binding to NR2C is necessary for NR2C trafficking, we
used a dominant-negative form of 14-3-33 (14-3-33 dn) to func-
tionally deplete 14-3-33 in neurons (Czirjak et al., 2008; Thorson
et al., 1998). We made a GFP-NR2C construct, which contains
a GFP tag in the extracellular N-terminal domain of the receptor,
to specifically label surface-expressed receptors. Cerebellar
granule cells were co-transfected with GFP-NR2C WT or GFP-
NR2C S1096A and Myc-14-3-33 or Myc-14-3-33 dn. We labeled
the surface-expressed receptors with anti-GFP antibody. Sur-
face expression of NR2C WT was dramatically decreased upon
cotransfection with 14-3-33 dn (Figure 4), indicating that the
interaction between NR2C and 14-3-3 is required for NR2C
trafficking. In addition, surface expression of NR2C S1096A
was much less than that of NR2C WT when 14-3-33 was coex-
pressed and was further reduced upon coexpression with
14-3-33 dn (Figure 4), suggesting that S1096 is not the sole
molecular determinant in 14-3-33-regulated NR2C trafficking.
Because IGF-1 has been shown to promote neuronal survival
by activating PKB and increased surface expression of NR2C
was driven by the same signaling pathway, we investigated
whether NR2C is involved in neuronal survival. Cultured cere-
bellar granule cells were co-transfected with vector, GFP-NR2A,
GFP-NR2B or GFP-NR2C and DsRed. At 6 DIV, the neurons
were incubated with NMDA to induce excitotoxicity (Bonfoco
et al., 1995). To closely monitor the effect of NMDA treatment,
we used time-lapse microscopy of DsRed-labeled neurons.
We found that neurons overexpressing NR2A or NR2B devel-
oped cell body swelling and dendritic varicosities within 5 min
following NMDA treatment (Figure 5A and Movie S1). Neurons
expressing DsRed alone also showed swelling of the cell body
and localized dendritic varicosities, although not as rapidly as
neurons expressing NR2A or NR2B. In sharp contrast, NR2C ex-
pressing neurons were protected from the NMDA-induced
toxicity (Figure 5A and Movie S1).
To determine if PKB-dependent trafficking of NR2C played
a role in cell survival, we evaluated toxicity in cerebellar granule
cells expressing NR2C WT or NR2C S1096A and found no differ-
ence in cell survival upon acute NMDA treatment (data not
shown). However, we analyzed older cultures (DIV8) and found
that neurons expressing NR2C S1096A displayed increased
dendritic fragmentation and varicosities compared to NR2C
WT, indicating neuronal injury (Hasbani et al., 2001). Quantitation
revealed that cerebellar granule cells expressing NR2C S1096A
showed almost double the number of neurons with dendritic
varicosities compared to NR2C WT-expressing cells (Figure 5B).
This is consistent with NR2C surface expression, and specifically
S1096, playing an important role in regulating cell survival.
DISCUSSION
In this study, we have revealed a growth factor-dependent
pathway for the subunit-specific regulation of cerebellar NMDA
receptors. We demonstrate that NR2C specifically interacts
with 14-3-33, that phosphorylation of S1096 on NR2C regulates
NMDA receptor binding to 14-3-3, and that S1096 is phosphor-
ylated by PKB. Furthermore, growth factor stimulation or NMDA
receptor activation increases NR2C S1096 phosphorylation and
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Figure 4. Disruption of 14-3-33 Binding to NR2C Reduces NR2C
Surface Expression
Cerebellar granule cells were cotransfected with NR2C containing an extracel-
lular GFP protein tag (GFP-NR2C) or GFP-NR2C S1096A and Myc-14-3-33WT
or Myc-14-3-33 dn. Two days after transfection, cells were incubated with anti-
GFP antibody for 30 min at room temperature. Cells were fixed and incubated
with Alexa 647-conjugated (blue) anti-rabbit secondary antibody to visualize
the surface receptors. Cells were then washed, permeabilized, and labeled
with anti-Myc monoclonal antibody and Alexa 568-conjugated (red) anti-
mouse secondary antibody to visualize the 14-3-33-transfected cells. The
Alexa 647 fluorescence is shown in green for visual effects. The right panels
show higher magnification images of boxed regions. Scale bar = 10 mm. The
data were quantified by measuring ratios of surface NR2C/total NR2C using
Metamorph software. Data represent means ± SEM (n = 3; *p < 0.05).Neuron 62, 471–478, May 28, 2009 ª2009 Elsevier Inc. 475
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roprotective
(A) Cerebellar granule cells (DIV4) were co-trans-
fected with DsRed and vector, GFP-NR2A, GFP-
NR2B, or GFP-NR2C. On DIV6, time-lapse imaging
was performed during exposure to NMDA (200mM).
DsRed was used to visualize the changes in cell
morphology of transfected neurons. NMDA treat-
ment resulted in cell body swelling and dendritic
varicosities of neurons expressing DsRed alone,
NR2A, or NR2B. Scale bar = 20 mm. Data shown
are representative of four independent experi-
ments.
(B) Cerebellar granule cells (DIV4) were cotrans-
fected with DsRed and GFP-NR2C WT or GFP-
NR2C S1096A. Cells were fixed on DIV8. The
images shown are representative of healthy and
sick neurons. The data were quantified by measur-
ing percentage of NR2C-expressing neurons with
dendritic fragmentation or varicosities. Data repre-
sent means ± SEM (n = 3; *p < 0.05).
A larger version of Figure 5 is available in the
Supplemental Data.surface expression of NMDA receptors in cerebellar granule
cells. These data are all consistent with a model in which NR1
and NR2C oligomerize, PKB phosphorylates S1096, and 14-3-33
binds to phosphorylated NR2C thereby promoting NR2C-con-
taining NMDA receptor surface expression in cerebellar granule
cells. Our findings therefore provide a direct link between growth
factor signaling, which is essential for cerebellar granule cell
survival, and NMDA receptor surface expression.
Our finding that the serine/threonine kinase PKB specifically
phosphorylates NR2C expands the list of kinases regulating
endogenous NMDA receptors and adds to the subunit-specific
complexity of NMDA receptor regulation. PKB has been studied
extensively vis a vis its role in cell cycle progression, apoptosis,
and cell signaling. In addition, PKB phosphorylation of many
distinct substrates can regulate protein-protein interactions
and protein trafficking (Brazil et al., 2004). We now show that
such a mechanism regulates NMDA receptor trafficking in the
cerebellum. Interestingly, NR2C S1096 is conserved in NR2A
(S1291) and NR2B (S1303), with the analogous serines being
substrates for PKC and/or CaMKII (Jones and Leonard, 2005;
Liao et al., 2001; Omkumar et al., 1996). However, the PKB
recognition motif is specific for NR2C, as is the consensus
sequence for 14-3-3 binding, suggesting a unique role for PKB
phosphorylation and 14-3-3 binding in NR2C-containing
NMDA receptor trafficking.
14-3-3 proteins act as molecular scaffolds or adapters to regu-
late intracellular signal transduction pathways (Berg et al., 2003).
Furthermore, recent findings show that in many cases 14-3-3
proteins mediate ER export of proteins (Shikano et al., 2006).
We now show that 14-3-33 preferentially associates with
oligomerized NR1/NR2C, consistent with a role in promoting
the forward trafficking of correctly assembled NR1/NR2C-con-
taining NMDA receptors. 14-3-3 proteins favor consensus
sequences containing phosphorylated serine residues (Yaffe
et al., 1997), and S1096 on NR2C is part of a strong consensus
motif for PKB phosphorylation. Because S1096 phosphorylation476 Neuron 62, 471–478, May 28, 2009 ª2009 Elsevier Inc.is required for the NR2C-14-3-3 interaction, our data suggest
that NMDA receptor egress from the ER is regulated by a
14-3-3-dependent mechanism as shown previously for other
multiprotein complexes (Shikano et al., 2006). However, this
type of PKB-dependent mechanism has never been described
for any glutamate receptor, and the specificity for NR2C
suggests a unique role in cerebellar function.
Growth factors play a critical role in regulating neuronal survival
during development (Pettmann and Henderson, 1998). Cerebellar
granule cells, in particular, are known to undergo a period of
extensive apoptosis during development, which is precisely regu-
lated by growth factors (Contestabile, 2002). IGF-1 has been
demonstrated to promote cerebellar granule cell survival both
in vitro and in vivo by blocking apoptosis (Chrysis et al., 2001;
D’Mello et al., 1997; Dudek et al., 1997). IGF-1 increases PI3
kinase activity leading to increased PKB activity and stimulation
of downstream kinase/signaling cascades (Brazil et al., 2004;
Datta et al., 1999). PKB phosphorylates a variety of substrates,
many of which regulate mitochondrial function and apoptosis
(Parcellier et al., 2008). Mice lacking various isoforms of PKB have
an overall reduction in cell number in many tissues, and specifi-
cally in the brain when the PKBg isoform is absent (Easton et al.,
2005; Tschopp et al., 2005). The growth factor/PKB signaling
pathway has been specifically implicated in regulating cerebellar
granule cell survival (D’Mello et al., 1997; Dudek et al., 1997).
Furthermore, there is evidence that PKB can potentiate NMDA
receptor responses in cerebellar granule cells (Sanchez-Perez
et al., 2006), suggesting a link between growth factor signaling
and receptor activation in these neurons. However, until now,
there was no mechanism described linking growth factor
signaling, PKB activity, and NMDA receptor expression.
In this study, we found that growth factor signaling and PKB
phosphorylation increase surface expression of NR2C-contain-
ing NMDA receptors. Importantly, we also showed that over-
expression of NR2C protects neurons from NMDA-induced
toxicity. Consistent with a role for phosphorylation of S1096 in
Neuron
PKB Regulates Cerebellar NMDA Receptor Traffickingreceptor trafficking, NR2C S1096A was less effective at neuronal
protection than NR2C WT, supporting a role for the PI3K/PKB
pathway in neuronal survival. We found that overexpression
of NR2C S1096A also has a protective effect compared to
NR2A or NR2B (data not shown), which is probably due to
the increased level of NR2C surface expression due to exo-
genous overexpression. For example, the S1096A mutation
does not completely abolish the surface expression of NR2C
when overexpressed in cerebellar granule cells (Figure 5). Our
results suggest that surface-expressed NR2C S1096A, even if
decreased compared to that of NR2C WT, is sufficient to support
neuronal survival. How does NR2C contribute to neuronal
survival? The answer probably lies in the fact that NR2C-contain-
ing NMDA receptors have unique channel properties (Dravid
et al., 2008) and that NR2C may mediate specific signaling path-
ways to activate downstream survival molecules. In conclusion,
our findings that PKB directly phosphorylates cerebellar NMDA
receptors and increases their surface expression reveals a novel
molecular mechanism by which growth factor signaling can
directly affect NMDA receptor activity.
EXPERIMENTAL PROCEDURES
DNA Constructs
The caPKB and dnPKB constructs were kindly provided by Michael Quon
(NCCAM, NIH). GFP-NR2A and GFP-NR2B were kindly provided by Stefano
Vicini (Georgetown University). Additional DNA construct information can be
found in Supplemental Data.
FACS Analysis
HEK293 cells were transiently transfected with NR1-1a-IRES-DsRed, FLAG-
NR2C-IRES-EGFP and vector, caPKB, or dnPKB. FACS analysis were per-
formed as described previously (Chen et al., 2006). Briefly, detached cells
were labeled with anti-FLAG M2 monoclonal antibodies (100 ng/ml) for 30 min
at 4C. Cells were incubated with phycoerythrin (PE)-Cy5-conjugated anti-
mouse secondary antibodies (100 ng/ml) for 30 min at 4C, washed and
suspended in PBS. The cells were immediately analyzed using a dual-laser
FACSVantage SE flow cytometer (Becton Dickinson, San Jose, CA). EGFP,
DsRed and PE-Cy5 signals were excited using a 488 nm laser light and the
resulting emissions captured with band pass filters set at 525 ± 20 nm, 575 ±
25 nm and 675 ± 20 nm, respectively.
Immunoprecipitation
The P2 membrane fractions (Chen et al., 2006) from P12 mouse cerebellar and
hippocampal slices was solubilized in PBS containing 1% SDS for 15 min at
37C. Ten volumes of PBS containing 1% Triton X-100 were added to the
lysate resulting in a final concentration of 0.1% SDS. Insoluble material was
removed by centrifugation at 100,000 g for 20 min. Immunoprecipitations
were performed as described previously (Chen et al., 2006).
Generation of Phosphorylation State-Specific Antibody
and Immunoblotting
Rabbits were immunized with a synthetic phosphopeptide Ac-RPRHA[pS]
LPSSVC-amide corresponding to amino acids 1091–1102 of NR2C by QCB
(Hopkinton, MA). Sera were collected and affinity-purified using the antigen
phosphopeptide. Anti-NR2C antibody was purchased from Chemicon Interna-
tional (Temecula, CA), anti-14-3-33 antibody was purchased from Santa Cruz
Biotechnology (Santa Cruz, CA), and FLAG and Myc antibody was purchased
from SIGMA. HEK293 cells were transfected with full-length NR2C WT or NR2C
S1096A using the calcium phosphate method (BD Biosciences, San Jose, CA)
and incubated with IGF-I for 20 min at 37C. Cell membranes were prepared as
described previously (Chen et al., 2006). Proteins were resolved by SDS-PAGE,
transferred to PVDF membrane, and immunoblotted with relevant antibodies.Immunocytochemistry of Neurons
Cultured cerebellar granule cells were transfected by the calcium phosphate
method at 4 DIV. After transfection, the cultures were maintained in the original
medium containing 25 mM KCl. At 6 DIV, immunocytochemistry was per-
formed as described previously (Lavezzari et al., 2004). Briefly, transfected
neurons were incubated with polyclonal anti-GFP antibody (Invitrogen) for
20 min at room temperature to label surface-expressed protein. The cells
were fixed and incubated with Alexa 647-conjugated (blue) anti-rabbit
secondary antibody (molecular Probes) for 30 min. The cells were permeabi-
lized, incubated with 10% normal goat serum, and labeled with monoclonal
anti-Myc antibody (9E10) for 30 min at room temperature. Following extensive
washing, cell were incubated with Alexa 568-conjugated (red) anti-mouse
secondary antibody for 30 min, and mounted with a ProLong Antifade kit
(Molecular Probes). Images were collected with a 633 objective on a Zeiss
LSM 510 confocal microscope. Series of optical sections collected at intervals
of 0.5 mm were used to create maximum projection images. For quantitative
analysis, images from three dendrites per neuron (three neurons per experi-
ment) were collected and quantitated using Metamorph 6.0 software. Blue
fluorescence intensity indicative of surface expression was divided by green
fluorescence intensity to control for the GFP-NR2C protein expression level.
Neurotoxicity Assay
At DIV4, cerebellar granule cells were transfected with DsRed and pRK5, GFP-
NR2A, GFP-NR2B, or GFP-NR2C. After transfection, the cultures were main-
tained in the original medium containing 25 mM KCl. At DIV6, time-lapse
imaging was performed for 25 min following NMDA treatment and collected
every 2.5 min. Confocal images were acquired using 403 objective. Serial
optical sections were obtained at 1 mm intervals. Movies were created
using Metamorph 6.0 software. Neurotoxicity was determined by the cell
morphology visualized by DsRed fluorescence.
Analysis of Dendritic Morphology
At DIV4, DsRed, and GFP-NR2C WT or S1096A were transfected at a ratio of
1:5. After transfection, the cultures were maintained in the original medium
containing 25 mM KCl. The experiments were terminated by fixing the cultures
at 8 DIV. The assessment of dendritic varicosities in older culture (DIV8, not
treated with NMDA) was determined as described previously (Hasbani et al.,
2001). Briefly, the presence of dendritic varicosities in DsRed-expressing
neurons was examined 4003 under epifluorescence illumination. For each
experimental condition, 100 DsRed-expressing neurons were scored for the
presence or absence of dendritic varicosities. The resulting values were aver-
aged for three independent experiments.
SUPPLEMENTAL DATA
The Supplemental Data include four supplemental figures, a larger version of
Figure 5, four movies, and Supplemental Experimental Procedures and can
be found with this article online at http://www.neuron.org/supplemental/
S0896-6273(09)00296-7.
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